Imaging Technology News - ITN

Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Feature | Radiology Imaging | By Brendon McHugh

How SDR is Enabling the Emerging Field of Microwave Tomography

While microwave tomography (MWT) imaging has been around for a few decades, advances in computing power, artificial ...

September 14, 2021

As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.

Feature | Magnetic Resonance Imaging (MRI) | By Melinda Taschetta-Millane

Incorporating Artificial Intelligence Into MRI

According to a new report produced by Grand View Research, the global magnetic resonance imaging (MRI) market size was ...

September 14, 2021

Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Feature | PET Imaging | By Todd Sasser, Ph.D.

The Role of PET Imaging in Preclinical Oncology

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to ...

September 14, 2021

Sponsored Content

Videos | Information Technology

IBA Dosimetry Features Compass 3.0 at AAPM 2013

IBA Dosimetry's Compass 3.0 is a unique two-in-one solution that allows the user to do both calculations and ...

August 13, 2013

Comparison Charts

Radiation Therapy Quality Assurance Platforms

Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated AI decision support tool for cardiac ultrasound.

News | Cardiovascular Ultrasound

FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler

September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and ...

September 14, 2021

Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and commercialization collaboration to evaluate the use of piflufolastat F 18, Lantheus’ prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agent, to enable real-time therapeutic guidance of biology-guided radiotherapy (BgRT) in prostate cancer using the RefleXion X1 platform.

News | PET Imaging

Lantheus and RefleXion Announce Collaboration with Potential to Improve Future Prostate Cancer Treatment

September 13, 2021 — Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and ...

September 13, 2021

With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

News | Radiation Oncology

Oncology Research Rebounds from Pandemic Low, But Shows Cancer Patients Need Attention After COVID-19 Recovery

September 13, 2021 — At the opening press conference of the ESMO Congress 2021, President Solange Peters announced that ...

September 13, 2021

Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

News | RSNA

RSNA 2021 Showcases Latest Imaging Technologies, Solutions

September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical ...

September 13, 2021

Ikonopedia announced that it has added Banner Health, one of the largest non-profit health care systems in the country, as a customer and will implement its entire suite of structured breast imaging reporting and MQSA management tools. The installation is designed to help streamline processes, improve reporting efficiency and optimize facility operations across the Banner Health network.

News | Breast Imaging

Ikonopedia to Implement Comprehensive Suite of Breast Imaging Report Generation and MQSA Management Capabilities at Banner Health

September 10, 2021 — Ikonopedia announced that it has added Banner Health, one of the largest non-profit health care ...

September 10, 2021

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life changing radiopharmaceuticals, today announced the signing of a supply agreement for the therapeutic medical radioisotope actinium-225 (Ac-225).

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes and POINT Biopharma Announce Supply Agreement for Therapeutic Medical Radioisotope Actinium-225

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

September 10, 2021

New recommendations will help provide more reliable, reproducible results for MRI-based measurements of cartilage degeneration in the knee, helping to slow down disease and prevent progression to irreversible osteoarthritis, according to a special report published in the journal Radiology

News | Magnetic Resonance Imaging (MRI)

RSNA Publishes New QIBA Profile for Knee Cartilage MRI

September 10, 2021 — New recommendations will help provide more reliable, reproducible results for magnetic resonance ...

September 10, 2021

This certification, which covers Agfa HealthCare’s Class IIa Enterprise Imaging and XERO Viewer solutions, ensures that Agfa HealthCare can continue to deliver to customers innovative solutions that meet their real challenges and address their needs and requirements.

News | Enterprise Imaging

Agfa HealthCare Receives MDR CE Certification for its Class IIa Solutions

September 9, 2021 — Agfa HealthCare is proud to be one of the first companies to receive the new European Medical Device ...

September 09, 2021

According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms during the coronavirus disease (COVID-19) pandemic promises a new and improved paradigm—reducing care disparities, while increasing the speed of diagnostic workup.

News | Breast Imaging

Same-day Mammogram Reading During COVID-19: Reduced Disparity, Faster Diagnosis

September 9, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms ...

September 09, 2021

Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch the disease earlier, according to Penn State College of Medicine researchers.

News | Breast Imaging

Legislation May Help Identify Breast Cancer Earlier in Certain At-risk Women

September 9, 2021 — Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch ...

September 09, 2021

Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

News | ASTRO

ASTRO Submits RO Model Comment Letters to CMS

September 9, 2021 — The American Society for Radiation Oncology (ASTRO) submitted two comment letters to the Centers for ...

September 09, 2021

A lone vendor booth in a sea of open space in a corner of the expo floor at HIMSS 2021 this week. A large number of vendors decided to pull out of exhibiting at HIMSS in recent weeks because the host city of Las Vegas saw a major surge of COVID cases over July, reaching a 20.2% positivity rate on the day HIMSS began.

Blog | HIMSS | By Dave Fornell, Editor

HIMSS 2021 Showed What to Expect From In-person Healthcare Conferences During the COVID Pandemic

The in-person 2021 Healthcare Information Management Systems Society (HIMSS) meeting planned for Aug. 9-13 appeared to ...

September 08, 2021

Insignia Medical Systems, a leading UK-based enterprise imaging provider, announced it has been acquired by Intelerad Medical Systems, a global leader in medical image management solutions. The deal signals an important step in expanding next-generation imaging solutions and resources to help modernise hospital trusts across the UK.

News | Radiology Business

Intelerad Acquires Insignia Medical Systems

September 8, 2021 — Insignia Medical Systems, a leading UK-based enterprise imaging provider, announced it has been ...

September 08, 2021

News | PET Imaging

Researchers Identify Mechanism That Can Help Guide Development of New STING-activating Drugs Using Imaging

September 8, 2021 — A new study from scientists at the UCLA Jonsson Comprehensive Cancer Center found that emerging ...

September 08, 2021

An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

News | Artificial Intelligence

Artificial Intelligence Could Help Diagnose Lung Cancer a Year Earlier

September 8, 2021 — An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) ...

September 08, 2021

62-Year-Old Woman Who Underwent Hysterectomy for Uterine Cancer: Sagittal chest CT images demonstrate measurement of right (A) and left (B) lung length at hilar level from apex to diaphragmatic dome. Right lung length was 20.1 cm for reader 1 and 20.0 cm for reader 2; left lung length was 21.7 cm for reader 1 and 21.3 cm for reader 2. Patient did not require postoperative mechanical ventilation.

News | Computed Tomography (CT)

Preoperative Chest CT Improves Assessment of Postoperative Mechanical Ventilation

September 7, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), preoperative thoracic computed ...

September 07, 2021